ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

2020 American Transplant Congress » Liver: Hepatocellular Carcinoma and Other Malignancies I

Date: Saturday, May 30, 2020

Time: 3:15pm-4:45pm

Location: Virtual

Session Type: Oral Abstract Session

Meeting: 2020 American Transplant Congress

3:15pm-3:27pm
Transarterial Chemoembolization and Radio-Embolization are Similarly Efficacious in Achieving Successful Hepatocellular Carcinoma (HCC) Down-Staging: Results from the Multicenter Evaluation of Reduction in Tumor Size Before Liver Transplantation (MERITS-LT) Consortium

N. Mehta1, J. Guy2, C. Frenette3, P. Tabrizian4, M. Hoteit5, N. Parikh6, T. Ghaziani7, R. Dhanasekaran7, J. L. Dodge1, M. L. Holzner4, S. Florman4, F. Yao1

3:27pm-3:39pm
Factors Associated with Hepatocellular Carcinoma Understaging for Liver Transplantation, and Variation in Understaging by Transplant Center

N. Mahmud1, M. Hoteit1, D. Goldberg2

3:39pm-3:51pm
Effects of Mandatory 6-Month Waiting Time Policy on Post-Transplant Outcomes and Explant Pathology in Liver Transplant Patients with Hepatocellular Carcinoma

S. Nagai, T. Kitajima, S. Yeddula, R. Salgia, M. Abouljoud, D. Moonka

3:51pm-4:03pm
National Trends in Locoregional Therapy among Liver Transplant (LT) Candidates with Hepatocellular Carcinoma (HCC) in the United States

A. Kwong1, W. Kim1, F. Yao2, N. Mehta2

4:03pm-4:15pm
Potential Benefits of Y-90 Radiation Microspheres for Bridging Liver Candidates with Hepatocellular Carcinoma to Liver Transplant

S. Pelletier1, J. Durden2, S. Shan2, P. Vargas3, N. Goldaracena1

4:15pm-4:27pm
Living Donor Liver Transplantation for Unresectable Liver Confined Colorectal Liver Metastases: A North American Experience

L. I. Ruffolo, K. Dokus, M. Larye, J. Errigo, J. Bhoely, R. Dunne, M. Levstik, B. Al-Jadaibi, K. Tomiyama, R. Hernandez-Alejandro

4:27pm-4:39pm
Younger Age is Associated with Improved Survival in Patients Undergoing Liver Transplantation Alone for Metastatic Neuroendocrine Tumors

R. Gedaly, D. Valvi, X. Mei, M. Gupta, M. Shah, A. Ancheta, F. Marti

« View all sessions from the 2020 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences